FiercePharmaAsia—Shingrix's Chinese nod; Chugai's $1B R&D site; Lilly's Verzenio safety woes
admin 24th May 2019 Uncategorised 0GlaxoSmithKline’s Shingrix wins nod to tackle China but won’t launch until 2020; Roche’s Chugai plunks down $1 billion for a new R&D site in Japan; Eli Lilly’s oncology rising star Verzenio faces a safety warning in Japan; and more. More:
read more